v3.26.3
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Apr. 15, 2025 $ 0 $ 0 $ 0 $ 0 $ 0
Balance (in Shares) at Apr. 15, 2025 0 0      
Class B ordinary shares issued to Sponsor [1] $ 0 $ 575 24,425 0 25,000
Class B ordinary shares issued to Sponsor (in Shares) [1] 0 5,750,000      
Net income (loss) $ 0 $ 0 0 (46,768) (46,768)
Balance at Jun. 30, 2025 $ 0 $ 575 24,425 (46,768) (21,768)
Balance (in Shares) at Jun. 30, 2025 0 5,750,000      
Balance at Apr. 15, 2025 $ 0 $ 0 0 0 0
Balance (in Shares) at Apr. 15, 2025 0 0      
Net income (loss)         941,404
Balance at Sep. 30, 2025 $ 66 $ 575 0 (8,030,606) (8,029,965)
Balance (in Shares) at Sep. 30, 2025 660,000 5,750,000      
Balance at Apr. 15, 2025 $ 0 $ 0 0 0 0
Balance (in Shares) at Apr. 15, 2025 0 0      
Accretion for Class A ordinary shares to redemption amount         (20,587,865)
Balance at Dec. 31, 2025 $ 66 $ 575 0 (8,277,853) (8,277,212)
Balance (in Shares) at Dec. 31, 2025 660,000 5,750,000      
Balance at Jun. 30, 2025 $ 0 $ 575 24,425 (46,768) (21,768)
Balance (in Shares) at Jun. 30, 2025 0 5,750,000      
Sale of 660,000 Private Placement Units $ 66   6,599,934   6,600,000
Sale of 660,000 Private Placement Units (in Shares) 660,000        
Fair value of Public Warrants at issuance     2,725,500   2,725,500
Offering costs allocated to Public Warrants     (188,765)   (188,765)
Assignment of Founder Shares to directors     155,040   155,040
Accretion for Class A ordinary shares to redemption amount     (9,316,134) (8,972,010) (18,288,144)
Net income (loss)       988,172 988,172
Balance at Sep. 30, 2025 $ 66 $ 575 0 (8,030,606) (8,029,965)
Balance (in Shares) at Sep. 30, 2025 660,000 5,750,000      
Balance at Dec. 31, 2025 $ 66 $ 575 0 (8,277,853) (8,277,212)
Balance (in Shares) at Dec. 31, 2025 660,000 5,750,000      
Accretion for Class A ordinary shares to redemption amount $ 0 $ 0 0 (1,961,704) (1,961,704)
Net income (loss) 0 0 0 1,673,135 1,673,135
Balance at Mar. 31, 2026 $ 66 $ 575 0 (8,566,422) (8,565,781)
Balance (in Shares) at Mar. 31, 2026 660,000 5,750,000      
Balance at Dec. 31, 2025 $ 66 $ 575 0 (8,277,853) (8,277,212)
Balance (in Shares) at Dec. 31, 2025 660,000 5,750,000      
Net income (loss)         5,373,223
Balance at Sep. 30, 2026 $ 66 $ 575 0 (9,148,504) (9,147,863)
Balance (in Shares) at Sep. 30, 2026 660,000 5,750,000      
Balance at Mar. 31, 2026 $ 66 $ 575 0 (8,566,422) (8,565,781)
Balance (in Shares) at Mar. 31, 2026 660,000 5,750,000      
Accretion for Class A ordinary shares to redemption amount $ 0 $ 0   (2,125,168) (2,125,168)
Net income (loss) 0 0 0 1,892,325 1,892,325
Balance at Jun. 30, 2026 $ 66 $ 575 0 (8,799,265) (8,798,624)
Balance (in Shares) at Jun. 30, 2026 660,000 5,750,000      
Accretion for Class A ordinary shares to redemption amount       (2,157,002) (2,157,002)
Net income (loss)       1,807,763 1,807,763
Balance at Sep. 30, 2026 $ 66 $ 575 $ 0 $ (9,148,504) $ (9,147,863)
Balance (in Shares) at Sep. 30, 2026 660,000 5,750,000      
[1] Includes up to 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on August 13, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no longer subject to forfeiture (see Note 5).